ArticleJournal of virology2005

Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies.

Bo Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.